Sara Suliman is an immunologist by training with a focus on understanding risk of progression to active TB disease and developing predictive biomarkers. She was an instructor at the Brigham and Women's Hospital and Harvard Medical Schools, where she focused on dissecting host factors associated with TB risk, including genetic associations and non-classical T cell responses to mycobacterial antigens. She also led the Mass General/Brigham COVID diagnostics accelerator lab. She is currently an assistant professor at the division of experimental medicine at UCSF and the Zuckerberg San Francisco General Hospital, where her lab focuses on identifying host mechanisms associated with TB progression.
